Neurofibromatosis

Neurofibromatosis is a genetic disorder that causes tumors to form in the central nervous system. While these tumors are typically benign, they can become malignant. Other complications of neurofibromatosis include hearing loss, learning impairment, vision loss, etc. Here is the latest research.

September 23, 2020
Open Access

STRIPAK regulates Slik localization to control mitotic morphogenesis and epithelial integrity

The Journal of Cell Biology
Camille Valérie De JamblinneSébastien Carréno
September 26, 2020

Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts

Pediatric Blood & Cancer
Erin ButlerStephen X Skapek
September 26, 2020

A modified human Myogenin promoter that is highly active in alveolar rhabdomyosarcoma

Cancer Gene Therapy
Johanna PrullerPeter S Zammit
September 26, 2020
Open Access

Improving the lives of children with neurofibromatosis type 1

Clinical and Experimental Pediatrics
Yoo-Mi Kim
September 28, 2020
Review

Clinical treatment options of early stage and advanced conjunctival melanoma

Survey of Ophthalmology
Yue ZengFang Wu
September 21, 2020
Open Access

Subungual Glomus Tumors: Underrecognized Clinical Findings in Neurofibromatosis 1

Journal of the American Academy of Dermatology
Shari R Lipner, Richard K Scher
September 24, 2020

Immunophenotypic characteristics of juvenile myelomonocytic leukaemia and their relation with the molecular subgroups of the disease

British Journal of Haematology
Anita Frisanco OliveiraLuiz Fernando Lopes
September 17, 2020

Breast cancer cell detection and characterization from breast milk-derived cells

Cancer Research
Poornima Bhat-NakshatriHarikrishna Nakshatri
September 18, 2020
Case Report
Open Access

Schwannoma and Neurofibroma, Originating from the Ulnar Nerve in Neurofibromatosis: A Case Report and Review of the Literature

The Surgery Journal
Ali TabriziHassan Taleb
September 22, 2020

18F-FDG PET/CT Helps Differentiate Peripheral Nerve Myeloid Sarcoma From a Presumed Benign Nerve Sheath Tumor

Clinical Nuclear Medicine
Jeeban P DasGary A Ulaner
September 19, 2020

Characterization of stromal tumor-infiltrating lymphocytes and genomic alterations in metastatic lobular breast cancer

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
François RichardChristine Desmedt
September 26, 2020

The Initial Appearance of Neurofibromatosis "Tumors" (von Recklinghausen's Disease) with the Onset of Pregnancy: A Clinical Letter

PM & R : the Journal of Injury, Function, and Rehabilitation
Myron M LaBan
September 22, 2020
Preprint
Open Access

Thoracoscopic Resection of Bilateral Multiple Superior Mediastinal Neurofibromas

ResearchSquare
Yoko AzumaAkira Iyoda
September 18, 2020
Case Report
Open Access

TMP3-NTRK1 rearranged uterine sarcoma: A case report

Case Reports in Women's Health
William BoyleRaji Ganesan
September 24, 2020

Angiotensin-(1-7) prevents T3-induced cardiomyocyte hypertrophy by upregulating FOXO3/SOD1/catalase and downregulating NF-ĸB

Journal of Cellular Physiology
Nathalia SengerMaria Luiza M Barreto-Chaves
September 21, 2020
Open Access

Neurofibromatosis Type 1 and Subungual Glomus Tumors: A Noteworthy Association

Journal of the American Academy of Dermatology
Robert A SchwartzMarc Zachary Handler

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

© 2020 Meta ULC. All rights reserved
/feed-previews/neurofibromatosis/39db2076-8010-4243-ae8c-1076acce931b